Tech Company Financing Transactions

CeNeRx BioPharma Funding Round

CeNeRx BioPharma closed a $18.5 million Series A investment round on 2/2/2007. Investors included Perseus, L Capital Partners and Pappas Ventures.

Transaction Overview

Company Name
Announced On
2/2/2007
Transaction Type
Venture Equity
Amount
$18,500,000
Round
Series A
Investors

Perseus (Lead Investor) (Steven Elms)

L Capital Partners (Ting Oei)

Pappas Ventures

Proceeds Purpose
The series A financing positions CeNeRx to advance critical research and development with ample reserves to support its future business growth initiatives.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
270 Cornerstone Dr. 103
Cary, NC 27519
USA
Email Address
Overview
CeNeRx (SEN-er-ex) is a privately held clinical stage company developing and commercializinginnovative and improved treatments for diseases of the central nervous system.
Profile
CeNeRx BioPharma LinkedIn Company Profile
Social Media
CeNeRx BioPharma Company Twitter Account
Company News
CeNeRx BioPharma News
Facebook
CeNeRx BioPharma on Facebook
YouTube
CeNeRx BioPharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Barry Brand
  Barry Brand LinkedIn Profile  Barry Brand Twitter Account  Barry Brand News  Barry Brand on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/1/2007: GigaSpaces Technologies venture capital transaction
Next: 2/2/2007: HydroPoint Data Systems venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary